Inicio/Acciones/NCNA

NCNA

USD

NuCana plc American Depositary Share

$3.630-0.120 (-3.200%)

Precio en Tiempo Real

Healthcare

Biotecnología

Reino Unido

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$3.750

Máximo

$3.920

Mínimo

$3.610

Volumen

0.09M

Fundamentos de la Empresa

Capitalización de Mercado

6.9M

Industria

Biotecnología

País

United Kingdom

Estadísticas de Negociación

Volumen Promedio

0.53M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $2.78Actual $3.630Máximo $332

Noticias Relacionadas

3 sept 2025 · 12:00

GlobeNewswire

NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025

EDINBURGH, United Kingdom, Sept. 03, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ:NCNA) ("NuCana" or the "Company") announced a presentation at the upcoming annual European Society for Medical Oncology ("ESMO") congress

NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025

20 ago 2025 · 20:05

GlobeNewswire

NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update

First Patients Dosed on Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with